Jong Hyuk Lee (JongHyuk Lee, Jong-Hyuk Lee)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Computed Tomography

End Stage Renal Disease

Health Insurance

Top Venues

Healthcare (Basel, Switzerland)

International journal of molecular sciences

Expert review of pharmacoeconomics & outcomes research

International journal of environmental research and public health

This page only lists publications with an associated author ORCID identifier.

Publications

Sungju Kim, Ji Yeon Lee, Seong Ha Cho, Eileen J Shin, Minyoung Kim, Jong Hyuk Lee
An Industry Survey on Unmet Needs in South Korea's New Drug Listing System. Therapeutic innovation & regulatory science (2023)
Seung-Hee Choi, Munkhzaya Byambaragchaa, Dae-Jung Kim, Jong Hyuk Lee, Myung-Hwa Kang, Kwan-Sik Min
Specific Signal Transduction of Constitutively Activating (D576G) and Inactivating (R476H) Mutants of Agonist-Stimulated Luteinizing Hormone Receptor in Eel. International journal of molecular sciences 24 (11) (2023)
Munkhzaya Byambaragchaa, Hong-Kyu Park, Dae-Jung Kim, Jong Hyuk Lee, Myung-Hwa Kang, Kwan-Sik Min
The N-Linked Glycosylation Site N191 Is Necessary for PKA Signal Transduction in Eel Follicle-Stimulating Hormone Receptor. International journal of molecular sciences 23 (21) (2022)
Jong Hyuk Lee
Pricing and Reimbursement Pathways of New Orphan Drugs in South Korea: A Longitudinal Comparison. Healthcare (Basel, Switzerland) 9 (3) (2021)
HoUng Kim, Rieke E Alten, J R Fraser Cummings, Silvio Danese, Geert R A M D'Haens, Paul Emery, Subrata Ghosh, Cyrielle Gilletta de Saint Joseph, Jong Hyuk Lee, James O Lindsay, Elena Nikiphorou, Ben Parker, Stefan Schreiber, Steven R A Simoens, René Westhovens, Ji Hoon Jeong, Laurent Peyrin-Biroulet
Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters. mAbs 13 (1) (2021)
Sungju Kim, Hyunyoung Cho, Jinhong Kim, Kyungmin Lee, Jong Hyuk Lee
The current state of patient access to new drugs in South Korea under the positive list system: evaluation of the changes since the new review pathways. Expert review of pharmacoeconomics & outcomes research 21 (1) (2020)
Ui Seok Kim, Jin Woo Park, Eon Sub Park, Joon Seok Bang, Tae Woo Jung, Dong-Seok Kim, A M Abd El-Aty, Jong Hyuk Lee, Ji Hoon Jeong
The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis. Pharmaceutics 12 (8) (2020)
Sungju Kim, Jong Hyuk Lee
Price-Cutting Trends in New Drugs after Listing in South Korea: The Effect of the Reimbursement Review Pathway on Price Reduction. Healthcare (Basel, Switzerland) 8 (3) (2020)
Se Hee Lee, Seung-Lai Yoo, Joon Seok Bang, Jong Hyuk Lee
Patient Accessibility and Budget Impact of Orphan Drugs in South Korea: Long-Term and Real-World Data Analysis (2007-2019). International journal of environmental research and public health 17 (9) (2020)
Sungju Kim, Jinhong Kim, Hyunyoung Cho, Kyungmin Lee, Chiyoung Ryu, Jong Hyuk Lee
Trends in the pricing and reimbursement of new anticancer drugs in South Korea: an analysis of listed anticancer drugs during the past three years. Expert review of pharmacoeconomics & outcomes research 21 (3) (2020)